789 results on '"van Laar, Jacob M."'
Search Results
2. Association of autoantibodies with the IFN signature and NETosis in patients with systemic lupus erythematosus
3. Concomitant prednisone may alleviate methotrexate side-effects in rheumatoid arthritis patients
4. Author Correction: Regulatory T cells in psoriatic arthritis: an IL-17A-producing, Foxp3intCD161 + RORγt + ICOS + phenotype, that associates with the presence of ADAMTSL5 autoantibodies
5. Long-term outcomes of COVID-19 vaccination in patients with rare and complex connective tissue diseases: The ERN-ReCONNET VACCINATE study
6. A tolerogenic dendritic cell–based therapy targeting heat shock protein–specific regulatory T cells in rheumatoid arthritis
7. Contributors
8. Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
9. Microarray analysis of autoantibodies can identify future Systemic Lupus Erythematosus patients
10. A phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud's
11. Predictors for progressive fibrosis in patients with connective tissue disease associated interstitial lung diseases
12. Clinical Practice Audit on the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in the Netherlands
13. Development and Validation of Rheumatoid Arthritis Disease Activity Indices Including HandScan (Optical Spectral Transmission) Scores
14. The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET
15. Publisher Correction: The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET
16. Health-related quality of life in patients with immune mediated inflammatory diseases: A cross-sectional, multidisciplinary study
17. Difficulté de prédire la réponse clinique au méthotrexate chez les patients atteints de polyarthrite rhumatoïde : revue systématique de la littérature
18. Is prediction of clinical response to methotrexate in individual rheumatoid arthritis patients possible? A systematic literature review
19. Efficacy of Tocilizumab Monotherapy Versus Tocilizumab and Methotrexate Combination Therapy in the Prevention of Radiographic Progression in Rheumatoid Arthritis: An Analysis Using Individual Patient Data From Multiple Clinical Trials
20. Identification and prediction of difficult-to-treat rheumatoid arthritis patients in structured and unstructured routine care data: results from a hackathon
21. Mycophenolate mofetil, azathioprine and tacrolimus: mechanisms in rheumatology
22. Systemic Sclerosis
23. Anti-thymocyte globulin exposure in patients with diffuse cutaneous systemic sclerosis undergoing autologous haematopoietic stem cell transplantation
24. Immunomodulatory, Immunoablative, and Biologic Therapies
25. Microbial Dysbiosis in Common Variable Immune Deficiencies: Evidence, Causes, and Consequences
26. Effectiveness of TOcilizumab in comparison to Prednisone In Rheumatoid Arthritis patients with insufficient response to disease-modifying antirheumatic drugs (TOPIRA): study protocol for a pragmatic trial
27. AZD9567 versus prednisolone in patients with active rheumatoid arthritis: A phase IIa, randomized, double‐blind, efficacy, and safety study.
28. Targeting the TLR4–MD2 axis in systemic sclerosis
29. Editorial: Stem cell transplantation in autoimmune diseases (AID)
30. Prognostication of progressive pulmonary fibrosis in connective tissue disease-associated interstitial lung diseases: A cohort study
31. Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial
32. Additional file 1 of Concomitant prednisone may alleviate methotrexate side-effects in rheumatoid arthritis patients
33. The multi-biomarker disease activity score tracks response to rituximab treatment in rheumatoid arthritis patients: a post hoc analysis of three cohort studies
34. Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combination: insights from systems biology
35. Hematopoietic stem-cell transplantation in systemic sclerosis: an update
36. Regulatory T cells in psoriatic arthritis: an IL-17A-producing, Foxp3intCD161 + RORγt + ICOS + phenotype, that associates with the presence of ADAMTSL5 autoantibodies
37. Haematopoietic stem cell transplantation for autoimmune diseases
38. Chapter 11 - A tolerogenic dendritic cell–based therapy targeting heat shock protein–specific regulatory T cells in rheumatoid arthritis
39. Immunomodulatory Therapies
40. Positron Emission Tomography to Improve Assessment of Interstitial Lung Disease in Patients With Systemic Sclerosis Eligible for Autologous Stem Cell Transplantation
41. Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria
42. Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)
43. Targeting of tolerogenic dendritic cells towards heat‐shock proteins: a novel therapeutic strategy for autoimmune diseases?
44. Immunosuppressive Drugs
45. Patient-reported outcomes in newly diagnosed early rheumatoid arthritis patients treated to target with a tocilizumab- or methotrexate-based strategy
46. Immunomodulatory, Immunoablative, and Biologic Therapies
47. Stem cell therapies
48. Cellular Therapies in Systemic Sclerosis: Recent Progress
49. Hematopoietic stem cell transplantation for the treatment of severe autoimmune diseases
50. Sjögren's syndrome and other rare and complex connective tissue diseases: an intriguing liaison
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.